CL

Clarivate PLCNYSE CLVT Stock Report

Last reporting period 30 Sep, 2024

Updated 20 Nov, 2024

Last price

Market cap $B

4.946

Middle

Exchange

XNYS - New York Stock Exchange, Inc

CLVT Stock Analysis

CL

Uncovered

Clarivate PLC is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

-26/100

Low score

Market cap $B

4.946

Dividend yield

Shares outstanding

674.43 B

Clarivate Plc engages in the provision of global information, analytics and workflow solutions. The firm provides content, analytics, professional services, and workflow solutions that enable users across government and academic institutions, life science companies, and research and development- intensive corporations to discover, protect and commercialize their innovations. Its three segments include Academia & Government (A&G), Life Sciences and Healthcare (LS&H), and Intellectual Property (IP). A&G segment provides curated, structured content, discovery solutions, and related software applications, which include libraries, universities, and research institutions. LS&H segment serves the content and analytical needs of pharmaceutical and biotechnology companies across the drug development lifecycle, including content on discovery and preclinical research, competitive intelligence, regulatory information and clinical trials. Its key products include Web of Science and Derwent, among others.

View Section: Eyestock Rating